{"id":"W1980747619","doi":"10.1053/j.seminoncol.2009.10.014","title":"Clinical Development of Temsirolimus, a Novel mTOR Inhibitor, for Treatment of Advanced Malignancies","year":2009,"lang":"en","type":"editorial","venue":"Seminars in Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Temsirolimus; Discovery and development of mTOR inhibitors; Medicine; PI3K/AKT/mTOR pathway; Sirolimus; Oncology; Cancer research; Internal medicine; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003853511,0.001752427,0.001948635,0.001067269,0.0008743048,0.002432986,0.001905928,0.008155296,0.003459606],"category_scores_gemma":[0.005925776,0.0005477439,0.001528182,0.0004664809,0.0008814944,0.001553563,0.0005541721,0.0123686,0.002588108],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001520374,"about_ca_system_score_gemma":0.001614553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008411654,"about_ca_topic_score_gemma":0.002308471,"domain_scores_codex":[0.9988006,0.0002253263,0.0001861934,0.0001352911,0.000541219,0.0001112484],"domain_scores_gemma":[0.9966744,0.001198422,0.0001974019,0.00006225576,0.001294147,0.0005734102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002255997,0.00003584973,0.00004549941,0.0004142263,0.00004785298,0.0003691335,0.00001057142,0.00007537066,0.0004624897,0.0006055281,0.9669871,0.03072082],"study_design_scores_gemma":[0.0003948979,0.0002035674,0.0005202264,0.0002926053,0.000144174,0.0008355378,0.00001306271,0.0003059134,0.0006692892,0.0005933798,0.9960058,0.00002154999],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.000429061,0.0471874,0.0008982666,0.07306166,0.8724203,0.00006843473,0.0001110214,0.0001112504,0.005712584],"genre_scores_gemma":[0.003729638,0.03569402,0.0008052527,0.05270833,0.8840924,0.0000655472,0.0001425414,0.00004597111,0.02271626],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.008155296,"threshold_uncertainty_score":0.0203796,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02357649989753213,"score_gpt":0.371626267336534,"score_spread":0.3480497674390018,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}